Kohei Miyata

1.6k total citations
75 papers, 1.2k citations indexed

About

Kohei Miyata is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kohei Miyata has authored 75 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Immunology. Recurrent topics in Kohei Miyata's work include RNA Interference and Gene Delivery (6 papers), Influenza Virus Research Studies (5 papers) and Advanced Drug Delivery Systems (5 papers). Kohei Miyata is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Influenza Virus Research Studies (5 papers) and Advanced Drug Delivery Systems (5 papers). Kohei Miyata collaborates with scholars based in Japan, United States and India. Kohei Miyata's co-authors include Hiroshi Asahara, Sho Mokuda, Merissa Olmer, Martin Lotz, Tokio Matsuzaki, Shingo Miyamoto, O. Alvarez-Garcia, Sung Ouk Nam, Fusanori Yotsumoto and Yukio Akasaki and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Kohei Miyata

72 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kohei Miyata Japan 18 603 237 200 146 130 75 1.2k
Hee Nam Kim South Korea 24 714 1.2× 127 0.5× 246 1.2× 213 1.5× 121 0.9× 88 1.5k
Kaya Yoshida Japan 24 753 1.2× 157 0.7× 77 0.4× 179 1.2× 179 1.4× 66 1.4k
Xinyue Huang China 14 564 0.9× 112 0.5× 104 0.5× 124 0.8× 185 1.4× 53 1.1k
Hirohiko Okamura Japan 23 939 1.6× 237 1.0× 78 0.4× 202 1.4× 209 1.6× 72 1.4k
Adriano Spreafico Italy 25 713 1.2× 76 0.3× 160 0.8× 159 1.1× 132 1.0× 50 1.6k
Eleni Mylona Greece 20 692 1.1× 180 0.8× 134 0.7× 364 2.5× 157 1.2× 43 1.4k
Rui Gong China 18 545 0.9× 297 1.3× 70 0.3× 172 1.2× 168 1.3× 54 1.2k
Hongye Fan China 23 486 0.8× 318 1.3× 122 0.6× 131 0.9× 518 4.0× 46 1.3k
Tiina Skoog Sweden 17 359 0.6× 201 0.8× 86 0.4× 165 1.1× 360 2.8× 27 1.1k

Countries citing papers authored by Kohei Miyata

Since Specialization
Citations

This map shows the geographic impact of Kohei Miyata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Miyata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Miyata more than expected).

Fields of papers citing papers by Kohei Miyata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Miyata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Miyata. The network helps show where Kohei Miyata may publish in the future.

Co-authorship network of co-authors of Kohei Miyata

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Miyata. A scholar is included among the top collaborators of Kohei Miyata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Miyata. Kohei Miyata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakabayashi, Kazuhiko, Noriko Ito, Kohei Miyata, et al.. (2025). Culture Medium Enriched with Ultrafine Carbon Monoxide Bubbles Enhances In Vitro Blastocyst Formation of In Vivo-Fertilized Mouse Zygotes. Antioxidants. 14(6). 684–684.
2.
Fujimoto, Koichi, et al.. (2023). Mucosal absorption of antibody drugs enhanced by cell-penetrating peptides anchored to a platform of polysaccharides. International Journal of Pharmaceutics. 647. 123499–123499. 4 indexed citations
3.
Miyamoto, Shingo, Yukiko Noguchi, Kohei Miyata, et al.. (2023). Physical Properties of Ultrafine Bubbles Generated Using a Generator System. In Vivo. 37(6). 2555–2563. 1 indexed citations
4.
Ukawa, Masami, et al.. (2022). Performance of Cell-Penetrating Peptides Anchored to Polysaccharide Platforms Applied via Various Mucosal Routes as an Absorption Enhancer. Molecular Pharmaceutics. 20(1). 303–313. 6 indexed citations
5.
UCHIDA, Y., Ryota Kurimoto, Tomoki Chiba, et al.. (2022). RNA-binding protein LIN28A upregulates transcription factor HIF1α by posttranscriptional regulation via direct binding to UGAU motifs. Journal of Biological Chemistry. 299(1). 102791–102791. 7 indexed citations
6.
Shirasu, Naoto, Kenichi Yoshikawa, Kohei Miyata, et al.. (2021). MicroRNAs miR-4535 and miR-1915-5p in Amniotic Fluid As Predictive Biomarkers for Chorioamnionitis. Future Science OA. 7(5). FSO686–FSO686. 4 indexed citations
7.
Yoshikawa, Kenichi, Kohei Miyata, Makoto Nomiyama, et al.. (2021). Diagnostic predictability of miR-4535 and miR-1915–5p expression in amniotic fluid for foetal morbidity of infection. Placenta. 114. 68–75. 6 indexed citations
8.
Suda, Wataru, Kohei Miyata, Fusanori Yotsumoto, et al.. (2021). Vaginal microbiome as a tool for prediction of chorioamnionitis in preterm labor: a pilot study. Scientific Reports. 11(1). 18971–18971. 11 indexed citations
9.
Ukawa, Masami, Yuki Yoshida, Kohei Miyata, et al.. (2019). Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses. Bioconjugate Chemistry. 30(12). 3028–3037. 9 indexed citations
10.
Mokuda, Sho, Ryo Nakamichi, Tokio Matsuzaki, et al.. (2019). Wwp2 maintains cartilage homeostasis through regulation of Adamts5. Nature Communications. 10(1). 2429–2429. 78 indexed citations
11.
Yotsumoto, Fusanori, Kenichi Yoshikawa, Kohei Miyata, et al.. (2019). Clinical Features of Recurrence in Patients Without Residual Tumour in Endometrial Cancer. Anticancer Research. 39(8). 4581–4588. 6 indexed citations
12.
Miyata, Kohei, Masami Ukawa, Kohta Mohri, et al.. (2018). Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery. Bioconjugate Chemistry. 29(5). 1748–1755. 15 indexed citations
13.
Miyata, Kohei, et al.. (2015). The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I Trial.. PubMed. 35(8). 4521–5. 5 indexed citations
14.
Miyata, Kohei, Tomoko Miyata, Kazuhiko Nakabayashi, et al.. (2014). DNA methylation analysis of human myoblasts during in vitro myogenic differentiation: de novo methylation of promoters of muscle-related genes and its involvement in transcriptional down-regulation. Human Molecular Genetics. 24(2). 410–423. 41 indexed citations
15.
Yotsumoto, Fusanori, Eriko Tokunaga, Eiji Oki, et al.. (2013). Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer. Molecular Cancer Research. 11(5). 506–517. 36 indexed citations
16.
Yoshinaga, Masao, et al.. (2004). Rapid increase in the prevalence of obesity in elementary school children. International Journal of Obesity. 28(4). 494–499. 46 indexed citations
17.
Yoshinaga, Masao, et al.. (2002). Who is becoming overweight during the elementary school years?. International Journal of Obesity. 26(10). 1317–1322. 7 indexed citations
18.
Maeno, Nobuaki, et al.. (2001). Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.. PubMed. 28(4). 860–4. 19 indexed citations
19.
Nomura, Yuichi, et al.. (1998). Twenty-five types of T-cell receptor Vβ family repertoire in patients with Kawasaki syndrome. European Journal of Pediatrics. 157(12). 981–986. 14 indexed citations
20.
Higuchi, I., Shuji Izumo, M Kuriyama, et al.. (1989). Germanium myopathy: clinical and experimental pathological studies. Acta Neuropathologica. 79(3). 300–304. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026